
T-cell lymphoma highlights at ASH 2022: unmet needs, clinical trial updates & future outlooks
VJHemOnc Podcast
00:00
Investigating C-Net Relapse and New Strategies for Treating T-cell Lymphoma
This chapter discusses the data about C-net relapse in T-cell lymphoma, including risk factors, incidence, and challenges of treatment. It also mentions studies on drugs like R2, laminar, azacitidine, and romidepsin, and highlights the potential of targeted trials for specific entities in T-cell lymphoma.
Transcript
Play full episode